Electrical stimulation of antagonist muscles after botulinum toxin type A for post-stroke spastic equinus foot. A randomized single-blind pilot study.
Aged
Botulinum Toxins, Type A
/ therapeutic use
Combined Modality Therapy
Electric Stimulation Therapy
Equinus Deformity
/ drug therapy
Female
Hemiplegia
/ drug therapy
Humans
Leg
Male
Middle Aged
Muscle Spasticity
/ drug therapy
Neuromuscular Agents
/ therapeutic use
Physical Endurance
Pilot Projects
Recovery of Function
Single-Blind Method
Stroke
Stroke Rehabilitation
Treatment Outcome
Botulinum toxin type A
Electrical stimulation
Rehabilitation
Spasticity
Stroke
Journal
Annals of physical and rehabilitation medicine
ISSN: 1877-0665
Titre abrégé: Ann Phys Rehabil Med
Pays: Netherlands
ID NLM: 101502773
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
received:
01
01
2019
revised:
10
06
2019
accepted:
10
06
2019
pubmed:
23
6
2019
medline:
28
1
2020
entrez:
23
6
2019
Statut:
ppublish
Résumé
Botulinum toxin type A (BoNT-A) injection is an effective treatment for lower-limb spasticity and should be offered as first-line treatment for focal manifestations. Although its possible role has been hypothesized, the efficacy of electrical stimulation (ES) of antagonists of the injected muscles for improving clinical outcome after BoNT-A injection remains to be established. This randomized single-blind pilot study aimed to investigate the efficacy of ES of antagonist muscles as adjunct treatment after BoNT-A injection to plantar flexor muscles in hemiplegic patients with spastic equinus foot. After BoNT-A injection at triceps surae, patients were randomly allocated to 2 groups: group 1, single ES session on injected muscles plus 5 sessions of ES on antagonist muscles, and group 2, single ES session on injected muscles alone. Both groups underwent daily physical therapy for 60min for 2 weeks (5 days/week). Assessments were performed before treatment (T The 30 patients enrolled were randomly allocated to the 2 groups: 15 in group 1 and 15 in group 2. At T ES of antagonist muscles does not improve clinical outcomes in the post-stroke spastic equinus foot after BoNT-A injection.
Sections du résumé
BACKGROUND
BACKGROUND
Botulinum toxin type A (BoNT-A) injection is an effective treatment for lower-limb spasticity and should be offered as first-line treatment for focal manifestations. Although its possible role has been hypothesized, the efficacy of electrical stimulation (ES) of antagonists of the injected muscles for improving clinical outcome after BoNT-A injection remains to be established.
OBJECTIVES
OBJECTIVE
This randomized single-blind pilot study aimed to investigate the efficacy of ES of antagonist muscles as adjunct treatment after BoNT-A injection to plantar flexor muscles in hemiplegic patients with spastic equinus foot.
METHODS
METHODS
After BoNT-A injection at triceps surae, patients were randomly allocated to 2 groups: group 1, single ES session on injected muscles plus 5 sessions of ES on antagonist muscles, and group 2, single ES session on injected muscles alone. Both groups underwent daily physical therapy for 60min for 2 weeks (5 days/week). Assessments were performed before treatment (T
RESULTS
RESULTS
The 30 patients enrolled were randomly allocated to the 2 groups: 15 in group 1 and 15 in group 2. At T
CONCLUSIONS
CONCLUSIONS
ES of antagonist muscles does not improve clinical outcomes in the post-stroke spastic equinus foot after BoNT-A injection.
Identifiants
pubmed: 31228593
pii: S1877-0657(19)30075-2
doi: 10.1016/j.rehab.2019.06.002
pii:
doi:
Substances chimiques
Neuromuscular Agents
0
Botulinum Toxins, Type A
EC 3.4.24.69
Types de publication
Comparative Study
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
214-219Informations de copyright
Copyright © 2019 Elsevier Masson SAS. All rights reserved.